Santen Aims at 1st-Line Use of Eybelis for Glaucoma Treatment: President

Santen President Shigeo Taniuchi Santen Pharmaceutical aims to make its new glaucoma treatment Eybelis ophthalmic solution (omidenepag isopropyl) a first-line treatment, President Shigeo Taniuchi said on November 9. “It has the potential to become a first-line treatment for the first...read more